Improved tolerability of ritonavir derived from pharmacokinetic principles

Br J Clin Pharmacol. 1996 Dec;42(6):787. doi: 10.1046/j.1365-2125.1996.d01-3339.x.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • HIV Protease Inhibitors / administration & dosage
  • HIV Protease Inhibitors / adverse effects*
  • HIV Protease Inhibitors / pharmacokinetics*
  • Humans
  • Ritonavir / administration & dosage
  • Ritonavir / adverse effects*
  • Ritonavir / pharmacokinetics*

Substances

  • HIV Protease Inhibitors
  • Ritonavir